http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2514638-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_314ceac477d91a62d862e66a925502ce |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
filingDate | 2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b1902fdffaec344b6f15ffb94cf1aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0790b99e3899508bbbb166e5b20497b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e88a78472e746809c9a4b02cc0de50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd3a78193a6a36b7dc3b75100ec0d34 |
publicationDate | 2014-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2514638-C1 |
titleOfInvention | Method of treating visual organ lymphomas |
abstract | FIELD: medicine. n SUBSTANCE: method provides conducting a radiation therapy to a total boost dose of 30-40 Gy. 60-90 Minutes before each session of the radiation therapy, 1% emoxipin is instilled 1-2 drops every 4-6 minutes for 30-40 minutes. The radiation session is immediately preceded by instillations of Coletex-gel-DNA-L hydrogel pre-dissolved in ratio 2:1 with an artificial tear preparation, 1-2 drops. Before bedtime, Coletex-gel-DNA hydrogel dissolved similarly is instilled in the same dose of 1-2 drops. After the radiation is completed, Coletex-gel-DNA hydrogel is instilled 2 times a day every 10-12 hours for 6-10 days. n EFFECT: method enables providing higher clinical effectiveness ensured by improving the protection of an anterior segment of the eyeball, reducing a degree of manifestation of radioreactions in a combination with a possibility to increase a total boost dose with no break in treatment. n 4 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2612006-C1 |
priorityDate | 2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.